News

First Busey Corporation Announces New Preferred Stock Offering

First Busey Corporation Announces New Preferred Stock Offering

First Busey Corporation's Preferred Stock Offering

First Busey Corporation, known for its stability and growth in the financial sector, has recently priced an exciting underwritten public offering. This offering encompasses 8,000,000 depositary shares, with each share representing a fraction of ownership in its 8.25% Fixed Rate Series B Non-Cumulative Perpetual Preferred Stock. The valuation for each of these shares stands at a liquidation preference of $1,000, effectively making each depositary share worth $25.00.

Details of the Offering

With this new offering, dividends on the Series B preferred stock are set at an annual rate of 8.25%, expected to be declared and paid out quarterly, which appeals to investors looking for consistent income. The set payment dates will include March 1, June 1, September 1, and December 1, commencing September 1, 2025. To enhance investor confidence, Busey has reserved the right to redeem shares at the original price, ensuring a steady return for early participants.

Use of Proceeds

The financial benefits from this offering are anticipated to support Busey’s commitment to balance sheet growth. Specifically, proceeds from the offering aim to redeem existing subordinated notes while simultaneously facilitating general corporate purposes. This approach underscores Busey’s strategic method of financial management and solidifies its footing as a resilient player in the banking industry.

Listing on Nasdaq

First Busey Corporation plans to list these depositary shares on the Nasdaq Global Select Market under the symbol 'BUSEP.' This step not only boosts the visibility of the offering but also reflects Busey’s growth trajectory as it aligns with investor interests.

Management and Advisors for the Offering

The underwriting task for this offering has been entrusted to esteemed financial institutions, including Piper Sandler & Co., Morgan Stanley & Co. LLC, and Keefe, Bruyette & Woods, Inc. Their expertise is crucial for ensuring the success of this public offering, marking another critical phase in Busey’s growth strategy. Janney Montgomery Scott LLC joins as a co-manager, further reinforcing the backing with extensive market knowledge.

Company Growth and Corporate Profile

As of March 31, 2025, First Busey Corporation boasts an impressive portfolio, featuring a total asset value of $19.46 billion and numerous banking centers across multiple states. This strategic positioning enables Busey to tap into diverse markets and enhance its operational capabilities.

Subsidiary Banking Operations

Busey Bank, as a wholly-owned subsidiary of First Busey Corporation, serves as a cornerstone of their operations with total assets of approximately $11.98 billion. With an extensive network of 62 banking centers across regions, Busey Bank provides critical financial services tailored to community needs.

Wealth Management Initiatives

First Busey Corporation's Wealth Management division also plays a pivotal role in its overall strategy, managing $13.68 billion in assets as of March 31, 2025. This division offers a wide range of services, including investment management, brokerage, and tax preparation. These services cater to individuals, businesses, and foundations, reinforcing the firm’s commitment to exceptional customer service.

Diverse Financial Technology Solutions

The market faced by Busey has evolved, and their subsidiary FirsTech rises to the occasion by providing innovative financial technology solutions. These include comprehensive payment options designed for small- and medium-sized businesses, ensuring Busey remains at the forefront of digital banking capabilities.

Acknowledgment and Recognition

First Busey Corporation has continuously garnered accolades within the banking sector. For the fourth consecutive year, it has been recognized among America’s Best Banks and received various awards for workplace excellence, showcasing its positive impact on both customers and employees alike. Busey's culture of integrity, engagement, and community commitment is consistently acclaimed, reinforcing its reputation as an employer of choice and a leader in financial services.

Frequently Asked Questions

What is First Busey Corporation's recent offering about?

The recent offering is about the pricing of 8,000,000 depositary shares of the Series B preferred stock, aimed at raising capital for the company.

What will be the use of the proceeds from this offering?

The proceeds are primarily intended to redeem existing subordinated notes and support general corporate purposes, including balance sheet growth.

When are the dividends expected to be paid?

Dividends on the Series B preferred stock will be payable quarterly, starting from September 1, 2025.

Where will the depositary shares be listed?

The depositary shares will be listed on the Nasdaq Global Select Market under the symbol 'BUSEP.'

How has First Busey Corporation been recognized recently?

First Busey has received multiple awards for workplace performance and is repeatedly listed among America’s Best Banks, highlighting its strong reputation in the financial industry.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading